← back to search

Morteza Sarmadi

Massachusetts Institute of Technology · US
Area of research
Pharmaceutical Science · Biomedical Engineering
Research interest
Research focused on Pulsatile flow and Coronavirus disease 2019 (COVID-19), with related work in Nanotechnology, Sting, Messenger RNA. Notable publications include 'Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy', 'A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines', and 'Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination'.
h-index
citations
676
works
8
NIH funding
primary concept
email

Recent publications

Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer
Science Advances 2024cited by 28position: middledoi
A Machine Learning-Optimized System for Pulsatile, Photo- and Chemotherapeutic Treatment Using Near-Infrared Responsive MoS<sub>2</sub>-Based Microparticles in a Breast Cancer Model
ACS Nano 2024cited by 14position: middledoi
A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines
Nature Biotechnology 2023cited by 170position: middledoi
Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines
Biomaterials 2023cited by 41position: middledoi
Experimental and computational understanding of pulsatile release mechanism from biodegradable core-shell microparticles
Science Advances 2022cited by 36position: firstdoi
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
Science Translational Medicine 2020cited by 187position: middledoi
Modeling, design, and machine learning-based framework for optimal injectability of microparticle-based drug formulations
Science Advances 2020cited by 67position: firstdoi
Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination
Science Translational Medicine 2019cited by 133position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Róbert Langer · Laboratoire d’immunologie intégrative du cancer6 papers (2020–2024)Ana Jaklenec · Massachusetts Institute of Technology6 papers (2020–2024)William T. Rothwell · Massachusetts Institute of Technology2 papers (2024–2024)Dominique C. De Fiesta · Massachusetts Institute of Technology2 papers (2022–2024)Shahad K. Alsaiari · Massachusetts Institute of Technology2 papers (2024–2024)Xueguang Lu · Massachusetts Institute of Technology2 papers (2020–2020)Zachary L. Tochka · Massachusetts Institute of Technology2 papers (2020–2020)Maria Kanelli · Massachusetts Institute of Technology2 papers (2022–2024)Nandita Menon · National University of Singapore2 papers (2022–2024)Adam M. Behrens · Massachusetts Institute of Technology2 papers (2020–2022)John L. Daristotle · Massachusetts Institute of Technology2 papers (2022–2024)Erika Yan Wang · University of Toronto2 papers (2023–2024)Kevin J. McHugh · Rice University2 papers (2020–2020)Nicole Henning · Massachusetts Institute of Technology1 papers (2024–2024)Wenting Gao · Hubei University of Medicine1 papers (2020–2020)Abigail M. VanLonkhuyzen · Massachusetts Institute of Technology1 papers (2022–2022)Lei Miao · University of North Carolina at Chapel Hill1 papers (2020–2020)Ziqi Chen · Massachusetts Institute of Technology1 papers (2020–2020)Kaitlyn Sadtler · National Institutes of Health1 papers (2020–2020)Stacey Qiaohui Lin · Massachusetts Institute of Technology1 papers (2024–2024)